ivonescimab

Product

First-in-class PD-1/VEGF bispecific antibody developed by Akeso for non-small cell lung cancer

2 stories

Researchers Present New Cancer Treatment Advances Including Immune Evasion Countermeasures and Chemo Alternatives

Contested Lung Cancer Drug Shows 34% Reduction in Death Risk in Late-Stage China Trial